Skip to main content

Advertisement

Table 2 Comparison between males and females

From: Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt

  Mean ± Std. Deviation t
Age
 • Male 49.48 ± 12.19 -3.68**
 • Female 58.34 ± 5.92  
PCR-T0
 • Male = 28 890248.43 ± 1049454.60 2.22*
 • Female = 28 411320.44 ± 451668.92  
BMI-T0
 • Male 29.10 ± 3.86 -2.83**
 • Female 31.99 ± 4.15  
MBI-T1
 • Male 28.88 ± 3.83 -2.74**
 • Female 31.88 ± 4.71  
HRQoL-T0
 • Male 23.73 ± 15.89 -3.43**
 • Female 39.06 ± 19.66
Symptom Severity-T0
 • Male 18.53 ± 10.30 -3.12**
 • Female 27.43 ± 12.28
Symptom Hindrance-T0
 • Male 5.20 ± 6.66 -3.27**
 • Female 11.62 ± 8.57
Depression-T0
 • Male 5.56 ± 5.88 -3.52**
 • Female 11.47 ± 7.19
Depression-T1
 • Male 7.20 ± 6.46 -2.32*
 • Female 11.28 ± 7.69
  1. Note: only significant results are presented, sample of male = 30 & female = 32
  2. PCR-T0 Polymerase Chain Reaction time0, BMI-T0 body mass index time 0, BMI-T1 body mass index time 1, HRQoL-T0 health-related quality of life time 0
  3. *P value: * ≤ .05, ** ≤ .001, *** ≤ .0001 at two tailed